跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Varivax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Varivax
Approved
STANDARD
Varivax
Merck Sharp & Dohme Corp.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
862a10eb4eb167e7
Company
Merck Sharp & Dohme Corp.
Type
Standard
Approval Details
Approval Id
862a10eb4eb167e7
Drug Approval Philippines Name
Varivax
Product Name
Varivax
Registration Number
BR-955
Brand Name
Varivax
Generic Name
Varicella Virus Vaccine, Live
Dosage Form
Lyophilized Powder For Solution for Injection (SC)
Dosage Strength
1350 PFU/0.5 mL
Manufacturer
Merck Sharp & Dohme Corp.
Importer
Merck Sharp & Dohme (I.A.) Corporation
Company Detail Path
/organization/merck-sharp-and-dohme-corp-united-states
Issuance Date
28 June 2024
Expiry Date
14 July 2029
Pharmacologic Category
Vaccine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
862a10eb4eb167e7
Type
Standard
Back to Philippines FDA Approvals